Related Experiment Videos

Vaccinia virus evasion of regulated cell death

David L Veyer1, Guia Carrara2, Carlos Maluquer de Motes3

  • 1Laboratoire de Virologie, Hôpital Européen Georges Pompidou, 20 Rue Leblanc, 75015 Paris, France.

Immunology Letters
|April 4, 2017
PubMed

Insights

Regulated cell death is a key antiviral defense. Vaccinia virus (VACV) proteins block these cell death pathways, impacting its use in vaccines and cancer therapy.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Regulated cell death is a critical host defense against viral infections, terminating viral replication and signaling to neighboring cells.
  • Viruses have evolved diverse mechanisms to evade host-induced cell death and ensure their survival.
  • Vaccinia virus (VACV), a poxvirus, encodes multiple proteins that actively interfere with host cell death pathways.

Purpose of the Study:

  • To review current knowledge of regulated cell death pathways.
  • To elucidate the mechanisms by which VACV proteins interact with and inhibit these cell death pathways.
  • To discuss the implications of VACV's anti-death strategies for its applications in vaccination and oncology.

Main Methods:

  • Literature review of existing research on regulated cell death and VACV.
  • Analysis of VACV protein functions in relation to host cell death signaling cascades (apoptosis, necroptosis, pyroptosis).
  • Synthesis of information on VACV's strategies to subvert host cell death.

Main Results:

  • VACV encodes multiple proteins that target and inhibit key components of apoptotic, necroptotic, and pyroptotic pathways.
  • VACV's interference with cell death is essential for successful viral replication within the host.
  • Understanding these viral countermeasures provides insights into host-pathogen interactions.

Conclusions:

  • VACV employs sophisticated strategies to counteract host-mediated regulated cell death.
  • Knowledge of VACV's manipulation of cell death pathways is crucial for optimizing its use as a vaccine vector.
  • VACV's ability to inhibit cell death pathways has potential therapeutic applications in cancer treatment as an oncolytic agent.

Related Concept Videos